Concepedia

Michele Mueller

MM

Statistics

Publications

6

Citations

332

H-Index

6

Active since

1999

Affiliations

Ohio Heart & Vascular Center(Current)

Christ Hospital

Center for Clinical Research (United States)

University of Massachusetts Chan Medical School

Community Health Alliance

Michele Mueller is an author at Ohio Heart & Vascular Center specializing in platelet aggregation inhibition, antithrombotic therapy, and medicine.

Publications per year

1999–2020

6

Publications

6

Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention

Dean J. Kereiakes, Thomas M. Broderick, Eli M. Roth et al. · The American Journal of Cardiology · 1999 · 134 citations

, , +17

The ultegra rapid platelet-function assay: Comparison to standard platelet function assays in patients undergoing percutaneous coronary intervention with abciximab therapy

Guy L. Wheeler, Gregory A. Braden, Steven R. Steinhubl et al. · American Heart Journal · 2002 · 54 citations

, , +17

Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein IIIa after percutaneous coronary intervention: Effects of dalteparin or unfractionated heparin in combination with abciximab

Mark I. Furman, Lori A. Krueger, Michele Mueller et al. · American Heart Journal · 2001 · 48 citations

, , +17

First Human Use of RUC‐4: A Nonactivating Second‐Generation Small‐Molecule Platelet Glycoprotein IIb/IIIa (Integrin αIIbβ3) Inhibitor Designed for Subcutaneous Point‐of‐Care Treatment of ST‐Segment–Elevation Myocardial Infarction

Dean J. Kereiakes, Tim Henry, Anthony N. DeMaria et al. · Journal of the American Heart Association · 2020 · 43 citations · Full text

, , +17

Efficacy of Abciximab Induced Platelet Blockade Using a Rapid Point of Care Assay

Michele Mueller, W L HOWARD, Pam Lacock et al. · Journal of Thrombosis and Thrombolysis · 1999 · 41 citations

, , +15

1–5 of 6